Sensitivity-related illness: The escalating pandemic of allergy, food intolerance and chemical sensitivity

Science of the Total Environment

Volumn 408, Issue 24, 2010, Pages 6047-6061

  Genuis, Stephen J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Allergy; Antibodies; Autoimmune disease; Cytokines; Detoxification; Environmental illness; Food intolerance; Inflammation; Multiple chemical sensitivity; Naltrexone; Sensitivity; Sensitivity related illness; Toxicant induced loss of tolerance; Toxicology

Indexed keywords

AUTOIMMUNE DISEASE; CYTOKINES; ENVIRONMENTAL ILLNESS; FOOD INTOLERANCE; INDUCED LOSS; INFLAMMATION; MULTIPLE CHEMICAL SENSITIVITY; NALTREXONE; SENSITIVITY; SENSITIVITY-RELATED ILLNESS; TOXICOLOGY;

ALLERGIES; ANTIBODIES; BIOCHEMISTRY; DETOXIFICATION; PATHOLOGY; TOXICITY;

CHEMICAL CONTAMINATION;

AFLATOXIN; ASCORBIC ACID; CASEIN; CURCUMIN; DOMESTIC CHEMICAL; EXCIPIENT; FLAVORING AGENT; FOOD ADDITIVE; FOOD ALLERGEN; GLUTAMATE SODIUM; GLUTEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 17; LACTOSE; MERCURY; MYCOTOXIN; NALTREXONE; OCHRATOXIN; PERFUME; PETROCHEMICAL AGENT; POLLEN ANTIGEN; RESVERATROL; RETINOL; STARCH; THIOCTIC ACID;

ALLERGY; ANTIBODY; DETOXIFICATION; DISEASE PREVALENCE; SENSITIVITY ANALYSIS; TOXICOLOGY;

ALLERGY; ANAMNESIS; AUTOIMMUNITY; AVOIDANCE BEHAVIOR; BIOACCUMULATION; CLINICAL FEATURE; CORN; DESENSITIZATION; DETOXIFICATION; DISINFECTION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EXHAUST GAS; HUMAN; HYPERSENSITIVITY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; MORBIDITY; MULTIPLE CHEMICAL SENSITIVITY; NEUROPSYCHOLOGY; NONHUMAN; NUTRITIONAL INTOLERANCE; NUTRITIONAL STATUS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SENSITIZATION; SOYBEAN; SYMPTOMATOLOGY;

AUTOIMMUNITY; BIOLOGICAL MARKERS; CHRONIC DISEASE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FOOD HYPERSENSITIVITY; HUMANS; HYPERSENSITIVITY; MULTIPLE CHEMICAL SENSITIVITY; PANDEMICS;

EID: 77958107727     PISSN: 00489697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2010.08.047     Document Type: Review

References (208)

1. Anandan C., Gupta R., Simpson C.R., Fischbacher C., Sheikh A. Epidemiology and disease burden from allergic disease in Scotland: analyses of national databases. J R Soc Med 2009, 102(10):431-442. Oct.
2. Anisman H., Merali A. Anhedonic and anxiogenic effects of cytokine exposure. Cytokines, Stress, and Depression 1999, Kluwer Academic/Plenum Publishers, New York.
3. 25th Annual International Symposium on Man and His Environment in Health and Disease: The Autonomic Nervous System. Dallas: June 7-10, 2007.
4. Anthoni S., Savilahti E., Rautelin H., Kolho K.L. Milk protein IgG and IgA: the association with milk-induced gastrointestinal symptoms in adults. World J Gastroenterol 2009, 15(39):4915-4918. Oct 21.
5. Ashford N., Miller C. Chemical exposures: low levels and high stakes 1998, John Wiley and Sons, New York. 2nd ed.
6. Barnes J.G. 'Sensitivity syndromes' related to radiation exposures. Med Hypotheses 2001, 57(4):453-458. Oct.
7. Bascom R. Multiple chemical sensitivity: a respiratory disorder?. Toxicol Ind Health 1992, 8(4):221-228. Jul-Aug.
8. Bell I.R., Miller C.S., Schwartz G.E. An olfactory-limbic model of multiple chemical sensitivity syndrome: possible relationships to kindling and affective spectrum disorders. Biol Psychiatry 1992, 32(3):218-242. Aug 1.
9. Bell I.R., Walsh M., Gross A., Gersmeyer J., Schwartz G., Kanof P. Cognitive dysfunction and disability in geriatric veterans with self-reported intolerance to environmental chemicals. J Chron Fatigue Syndr 1997, 3(3):15-42.
10. Bell I.R., Szarek M.J., Dicenso D.R., Baldwin C.M., Schwartz G.E., Bootzin R.R. Patterns of waking EEG spectral power in chemically intolerant individuals during repeated chemical exposures. Int J Neurosci 1999, 97(1-2):41-59. Mar.
11. Berg N.D., Linneberg A., Dirksen A., Elberling J. Prevalence of self-reported symptoms and consequences related to inhalation of airborne chemicals in a Danish general population. Int Arch Occup Environ Health 2008, 81(7):881-887. Jul.
12. Bernardi D., Borghesan F., Faggian D., Bianchi F.C., Favero E., Billeri L., et al. Time to reconsider the clinical value of immunoglobulin G4 to foods?. Clin Chem Lab Med 2008, 46(5):687-690.
13. Bjorksten B. The hygiene hypothesis: do we still believe in it?. Nestle Nutr Workshop Ser 2009, 64:11-22.
14. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007, 8(1):57-69. Jan.
15. Blonski W., Lichtenstein G.R. Safety of biologics in inflammatory bowel disease. Curr Treat Options Gastroenterol 2006, 9(3):221-233. Jun.
16. Bongartz T., Sutton A.J., Sweeting M.J., Buchan I., Matteson E.L., Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006, 295(19):2275-2285. May 17.
17. Bralley J.A., Lord R.S. Laboratory evaluations in molecular medicine: nutrients, toxicants, and cell regulators 2005, The Institute for Advances in Molecular Medicine, Norcross GA.
18. Branum A.M., Lukacs S.L. Food allergy among children in the United States. Pediatrics 2009, 124(6):1549-1555. Dec.
19. Brautbar N., Campbell A., Vojdani A. Silicone breast implants and autoimmunity: causation, association, or myth?. J Biomater Sci 1995, 7(2):133-145.
20. Brown N., Panksepp J. Low-dose naltrexone for disease prevention and quality of life. Med Hypotheses 2009, 72(3):333-337. Mar.
21. Brown J.M., Pfau J.C., Pershouse M.A., Holian A. Silica, apoptosis, and autoimmunity. J Immunotoxicol 2005, 1(3):177-187. Jul 1.
22. Buchwald D., Garrity D. Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. Arch Intern Med 1994, 154(18):2049-2053. Sep 26.
23. Cabrera-Chavez F., de la Barca A.M. Bovine milk intolerance in celiac disease is related to IgA reactivity to alpha- and beta-caseins. Nutrition 2009, 25(6):715-716. Jun.
24. Cathcart R.F. The vitamin C treatment of allergy and the normally unprimed state of antibodies. Med Hypotheses 1986, 21(3):307-321. Nov.
25. Centers for Disease Control, Department of Health and Human Services. Fourth National Report on Human Exposure to Environmental Chemicals. 2009. [Accessed Jan 18, 2009] Atlanta: Georgia. pp. 1-529. 2009. http://www.cdc.gov/exposurereport/pdf/FourthReport.pdf.
26. Cha H.R., Chang S.Y., Chang J.H., Kim J.O., Yang J.Y., Kim C.H., et al. Downregulation of Th17 cells in the small intestine by disruption of gut flora in the absence of retinoic acid. J Immunol 2010, 184:6799-6806.
27. Ciprandi G., De Amici M., Tosca M.A., Negrini S., Puppo F., Marseglia G.L. Immunoglobulin production pattern is allergen-specific in polysensitized patients. Int J Immunopathol Pharmacol 2009, 22(3):809-817. Jul-Sep.
28. Clark A.T., Islam S., King Y., Deighton J., Anagnostou K., Ewan P.W. Successful oral tolerance induction in severe peanut allergy. Allergy 2009, 64(8):1218-1220. Aug.
29. Cochrane S., Beyer K., Clausen M., Wjst M., Hiller R., Nicoletti C., et al. Factors influencing the incidence and prevalence of food allergy. Allergy 2009, 64(9):1246-1255. Sep.
30. Cohn W.J., Boylan J.J., Blanke R.V., Fariss M.W., Howell J.R., Guzelian P.S. Treatment of chlordecone (Kepone) toxicity with cholestyramine. Results of a controlled clinical trial. N Engl J Med 1978, 298(5):243-248. Feb 2.
31. Colbert L.H., Visser M., Simonsick E.M., Tracy R.P., Newman A.B., Kritchevsky S.B., et al. Physical activity, exercise, and inflammatory markers in older adults: findings from the Health, Aging and Body Composition Study. J Am Geriatr Soc 2004, 52(7):1098-1104. Jul.
32. Cone J.E., Sult T.A. Acquired intolerance to solvents following pesticide/solvent exposure in a building: a new group of workers at risk for multiple chemical sensitivities?. Toxicol Ind Health 1992, 8(4):29-39. Jul-Aug.
33. Cullen M. The worker with multiple chemical sensitivities: an overview. Workers with multiple chemical sensitivities: occupation medicine - state of the art reviews 1987, 2(4):655-662. Hanley and Belfus, Philadelphia. M. Cullen (Ed.).
34. Czura C.J., Tracey K.J. Autonomic neural regulation of immunity. J Intern Med 2005, 257(2):156-166. Feb.
35. Dahlgren J., Takhar H., Anderson-Mahoney P., Kotlerman J., Tarr J., Warshaw R. Cluster of systemic lupus erythematosus (SLE) associated with an oil field waste site: a cross sectional study. Environ Health 2007, 6:8.
36. Dahlgren J., Cecchini M., Takhar H., Paepke O. Persistent organic pollutants in 9/11 world trade center rescue workers: reduction following detoxification. Chemosphere 2007, 69(8):1320-1325. Oct.
37. D'Amato G., Cecchi L. Effects of climate change on environmental factors in respiratory allergic diseases. Clin Exp Allergy 2008, 38(8):1264-1274. Aug.
38. D'Amato G., Liccardi G., D'Amato M., Holgate S. Environmental risk factors and allergic bronchial asthma. Clin Exp Allergy 2005, 35(9):1113-1124. Sep.
39. Das-Munshi J., Rubin G.J., Wessely S. Multiple chemical sensitivities: a systematic review of provocation studies. J Allergy Clin Immunol 2006, 118(6):1257-1264. Dec.
40. De Luca C., Scordo M.G., Cesareo E., Pastore S., Mariani S., Maiani G., et al. Biological definition of multiple chemical sensitivity from redox state and cytokine profiling and not from polymorphisms of xenobiotic-metabolizing enzymes. Toxicol Appl Pharmacol 2010, Apr 27.
41. De Santis A., Addolorato G., Romito A., Caputo S., Giordano A., Gambassi G., et al. Schizophrenic symptoms and SPECT abnormalities in a coeliac patient: regression after a gluten-free diet. J Intern Med 1997, 242(5):421-423. Nov.
42. Desjardins S., Doyen C., Contejean Y., Kaye K., Paubel P. Treatment of a serious autistic disorder in a child with Naltrexone in an oral suspension form. Encephale 2009, 35(2):168-172. Apr.
43. Development. DoHaU. Subsection 802(h) of the Fair Housing Act, 42 U.S.C. 3602(h), and the Department's implementing regulation, 24 C.F.R. 100.201. 1991.
44. Dijkers M.P. The value of traditional reviews in the era of systematic reviewing. Am J Phys Med Rehabil 2009, 88(5):423-430. May.
45. Doherty S. History of evidence-based medicine. Oranges, chloride of lime and leeches: barriers to teaching old dogs new tricks. Emerg Med Australas 2005, 17(4):314-321. Aug.
46. Dong C. Differentiation and function of pro-inflammatory Th17 cells. Microbes Infect 2009, 11:584-588.
47. Duramad P., Tager I.B., Holland N.T. Cytokines and other immunological biomarkers in children's environmental health studies. Toxicol Lett 2007, 172(1-2):48-59. Jul 30.
48. Duvnjak L., Duvnjak M. The metabolic syndrome - an ongoing story. J Physiol Pharmacol 2009, 60(Suppl 7):19-24. Dec.
49. Edmondson D.A., Nordness M.E., Zacharisen M.C., Kurup V.P., Fink J.N. Allergy and "toxic mold syndrome". Ann Allergy Asthma Immunol 2005, 94(2):234-239. Feb.
50. Ellman L.M., Deicken R.F., Vinogradov S., Kremen W.S., Poole J.H., Kern D.M., et al. Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8. Schizophr Res 2010, 121(1-3):46-54. Aug.
51. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005, 115(5):911-919. May, quiz 920.
52. Fernandez M., Bell I.R., Schwartz G.E. EEG sensitization during chemical exposure in women with and without chemical sensitivity of unknown etiology. Toxicol Ind Health 1999, 15(3-4):305-312. Apr-Jun.
53. Fiedler N., Kipen H., Natelson B., Ottenweller J. Chemical sensitivities and the Gulf War: Department of Veterans Affairs Research Center in basic and clinical science studies of environmental hazards. Regul Toxicol Pharmacol 1996, 24(1 Pt 2):S129-S138. Aug.
54. Fiedler N., Giardino N., Natelson B., Ottenweller J.E., Weisel C., Lioy P., et al. Responses to controlled diesel vapor exposure among chemically sensitive Gulf War veterans. Psychosom Med 2004, 66(4):588-598. Jul-Aug.
55. Fincher C.E., Chang T.S., Harrell E.H., Kettelhut M.C., Rea W.J., Johnson A., et al. Comparison of single photon emission computed tomography findings in cases of healthy adults and solvent-exposed adults: correction of previous results. Am J Ind Med 1997, 32(6):693-694. Dec.
56. Fincher C.E., Chang T.S., Harrell E.H., Kettelhut M.C., Rea W.J., Johnson A., et al. Comparison of single photon emission computed tomography findings in cases of healthy adults and solvent-exposed adults. Am J Ind Med 1997, 31(1):4-14. Jan.
57. Freeman H.J. Celiac disease (gluten-sensitive enteropathy). Minerva Gastroenterol Dietol 2010, 56(2):245-249. Jun.
58. Fukuda K., Nisenbaum R., Stewart G., Thompson W.W., Robin L., Washko R.M., et al. Chronic multisymptom illness affecting Air Force veterans of the Gulf War. JAMA 1998, 280(11):981-988. Sep 16.
59. Fukuyama T., Ueda H., Hayashi K., Tajima Y., Shuto Y., Saito T.R., et al. Detection of low-level environmental chemical allergy by a long-term sensitization method. Toxicol Lett 2008, 180(1):1-8. Jul 30.
60. Gauderman W.J., Avol E., Lurmann F., Kuenzli N., Gilliland F., Peters J., et al. Childhood asthma and exposure to traffic and nitrogen dioxide. Epidemiology 2005, 16(6):737-743. Nov.
61. Gelincik A., Buyukozturk S., Gul H., Isik E., Issever H., Ozseker F., et al. Confirmed prevalence of food allergy and non-allergic food hypersensitivity in a Mediterranean population. Clin Exp Allergy 2008, 38(8):1333-1341. Aug.
62. Genuis S.J. The chemical erosion of human health: adverse environmental exposure and in-utero pollution - determinants of congenital disorders and chronic disease. J Perinat Med 2006, 34:185-195.
63. Genuis S.J. Health issues and the environment - an emerging paradigm for providers of obstetrical and gynecological healthcare. Hum Reprod 2006, 21:2201-2208.
64. Genuis S.J. Our genes are not our destiny: incorporating molecular medicine into clinical practice. J Eval Clin Pract 2008, 14(1):94-102. Feb.
65. Genuis S.J. Medical practice and community health care in the 21st century: a time of change. Public Health 2008, 122(7):671-680. Jul.
66. Genuis S.J. Toxic causes of mental illness are overlooked. Neurotoxicology 2008, 29(6):1147-1149. Nov.
67. Genuis S.J. Nowhere to hide: chemical toxicants and the unborn child. Reprod Toxicol (Elmsford, N.Y.) 2009, 28(1):115-116. Jul.
68. Genuis S.J. Evolution in pediatric health care. Pediatr Int 2010, 10.1111/j.1442-200X.2010.03106.x.
69. Genuis S.J. Elimination of persistent toxicants from the human body. Hum Exp Toxicol 2010, Apr 20.
70. Genuis S.J. Human detoxification of perfluorinated compounds. Public Health 2010, 124(7):367-375. Jul.
71. Genuis S.J., Bouchard T.P. Celiac disease presenting as autism. J Child Neurol 2010, 25:114-119.
72. Genuis S.K., Genuis S.J. Exploring the continuum: medical information to effective clinical practice: Paper 1. The translation of knowledge into clinical practice. J Eval Clin Pract 2006, 12:49-62.
73. Genuis S.J., Lobo R.A. Potential amelioration of morbidity in patients with chromosomal anomalies: relevance to Bardet-Biedl syndrome. Clin Genet 2010, Jun 21.
74. Gibson P.R., Vogel V.M. Sickness-related dysfunction in persons with self-reported multiple chemical sensitivity at four levels of severity. J Clin Nurs 2009, 18(1):72-81. Jan.
75. Gilbert K.M., Pumford N.R., Blossom S.J. Environmental contaminant trichloroethylene promotes autoimmune disease and inhibits T-cell apoptosis in MRL(+/+) mice. J Immunotoxicol 2006, 3(4):263-267. Dec 1.
76. Gironi M., Martinelli-Boneschi F., Sacerdote P., Solaro C., Zaffaroni M., Cavarretta R., et al. A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis. Mult Scler (Houndmills, Basingstoke, England) 2008, 14(8):1076-1083. Sep.
77. Gold D.R., Wright R. Population disparities in asthma. Annu Rev Public Health 2005, 26:89-113.
78. Gordon M. Reactions to chemical fumes in radiology departments. Radiography 1987, 53(608):85-89. Mar-Apr.
79. Graveling R.A., Pilkington A., George J.P., Butler M.P., Tannahill S.N. A review of multiple chemical sensitivity. Occup Environ Med 1999, 56(2):73-85. Feb.
80. Gupta R.S., Kim J.S., Barnathan J.A., Amsden L.B., Tummala L.S., Holl J.L. Food allergy knowledge, attitudes and beliefs: focus groups of parents, physicians and the general public. BMC Pediatr 2008, 8:36.
81. Hausteiner C., Bornschein S., Hansen J., Zilker T., Forstl H. Self-reported chemical sensitivity in Germany: a population-based survey. Int J Hyg Environ Health 2005, 208(4):271-278.
82. Helms D.J., Mosure D.J., Secor W.E., Workowski K.A. Management of trichomonas vaginalis in women with suspected metronidazole hypersensitivity. Am J Obstet Gynecol 2008, 198(4):370. Apr, e371-377.
83. Heuser G., Wu J.C. Deep subcortical (including limbic) hypermetabolism in patients with chemical intolerance: human PET studies. Ann NY Acad Sci 2001, 933:319-322. Mar.
84. Hillert L., Musabasic V., Berglund H., Ciumas C., Savic I. Odor processing in multiple chemical sensitivity. Hum Brain Mapp 2007, 28(3):172-182. Mar.
85. Hintikka E.L. The role of stachybotrys in the phenomenon known as sick building syndrome. Adv Appl Microbiol 2004, 55:155-173.
86. Hirvonen M.R., Nevalainen A., Makkonen N., Monkkonen J., Savolainen K. Induced production of nitric oxide, tumor necrosis factor, and interleukin-6 in RAW 264.7 macrophages by streptomycetes from indoor air of moldy houses. Arch Environ Health 1997, 52(6):426-432. Nov-Dec.
87. Hirvonen M.R., Ruotsalainen M., Roponen M., Hyvarinen A., Husman T., Kosma V.M., et al. Nitric oxide and proinflammatory cytokines in nasal lavage fluid associated with symptoms and exposure to moldy building microbes. Am J Respir Crit Care Med 1999, 160(6):1943-1946. Dec.
88. Hirvonen M.R., Huttunen K., Roponen M. Bacterial strains from moldy buildings are highly potent inducers of inflammatory and cytotoxic effects. Indoor Air 2005, 15(Suppl 9):65-70.
89. Hobbs A. The sick house survival guide 2003, New Society Publishers, Gabriola Island, British Columbia.
90. Hsueh K.C., Lin Y.J., Lin H.C., Lin C.Y. Serum leptin and adiponectin levels correlate with severity of allergic rhinitis. Pediatr Allergy Immunol 2009, Aug 30.
91. Ishimaru N., Takagi A., Kohashi M., Yamada A., Arakaki R., Kanno J., et al. Neonatal exposure to low-dose 2,3,7,8-tetrachlorodibenzo-p-dioxin causes autoimmunity due to the disruption of T cell tolerance. J Immunol 2009, 182(10):6576-6586. May 15.
92. Isolauri E., Kalliomaki M., Rautava S., Salminen S., Laitinen K. Obesity - extending the hygiene hypothesis. Nestle Nutr Workshop Ser 2009, 64:75-89.
93. Jalava P.I., Salonen R.O., Pennanen A.S., Happo M.S., Penttinen P., Halinen A.I., et al. Effects of solubility of urban air fine and coarse particles on cytotoxic and inflammatory responses in RAW 264.7 macrophage cell line. Toxicol Appl Pharmacol 2008, 229(2):146-160. Jun 1.
94. Jalava P.I., Hirvonen M.R., Sillanpaa M., Pennanen A.S., Happo M.S., Hillamo R., et al. Associations of urban air particulate composition with inflammatory and cytotoxic responses in RAW 246.7 cell line. Inhal Toxicol 2009, 21(12):994-1006. Oct.
95. Jedrychowski W., Galas A., Whyatt R., Perera F. The prenatal use of antibiotics and the development of allergic disease in one year old infants. A preliminary study. Int J Occup Med Environ Health 2006, 19(1):70-76.
96. Joffres M.R., Williams T., Sabo B., Fox R.A. Environmental sensitivities: prevalence of major symptoms in a referral center: the Nova Scotia Environmental Sensitivities Research Center Study. Environ Health Perspect 2001, 109(2):161-165. Feb.
97. Johansson O. Electrohypersensitivity: state-of-the-art of a functional impairment. Electromagn Biol Med 2006, 25(4):245-258.
98. Johansson A., Bramerson A., Millqvist E., Nordin S., Bende M. Prevalence and risk factors for self-reported odour intolerance: the Skovde population-based study. Int Arch Occup Environ Health 2005, 78(7):559-564. Aug.
99. Jones S.M., Pons L., Roberts J.L., Scurlock A.M., Perry T.T., Kulis M., et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 2009, 124(2):292-300. Aug, 300 e291-297.
100. Kalinina N.H., Nikiforova I.D., Syssoev K.A., Sidorenko V.A. Immunological aspects of osteoporosis in Chernobyl cleanup workers. Conference proceedings. International conference on the effects of low and very low doses of ionizing radiation on human health: June 16-18, 1999 1999, 48.
101. Kalliomaki M., Isolauri E. Pandemic of atopic diseases-a lack of microbial exposure in early infancy?. Curr Drug Targets 2002, 2(3):193-199. Sep.
102. Kariv R., Tiomny E., Grenshpon R., Dekel R., Waisman G., Ringel Y., et al. Low-dose naltreoxone for the treatment of irritable bowel syndrome: a pilot study. Dig Dis Sci 2006, 51(12):2128-2133. Dec.
103. Kawaguchi M., Kokubu F., Fujita J., Huang S.K., Hizawa N. Role of interleukin-17F in asthma. Inflamm Allergy Drug Targets 2009, 8:383-389.
104. Kilburn K.H. Effects of hydrogen sulfide on neurobehavioral function. South Med J 2003, 96(7):639-646. Jul.
105. Kilburn K.H., Warsaw R.H., Shields M.G. Neurobehavioral dysfunction in firemen exposed to polychlorinated biphenyls (PCBs): possible improvement after detoxification. Arch Environ Health 1989, 44:345-350.
106. Kim C.H. Regulation of FoxP3 regulatory T cells and Th17 cells by retinoids. Clin Dev Immunol 2008, 2008:416910.
107. Kimata H. Exposure to road traffic enhances allergic skin wheal responses and increases plasma neuropeptides and neurotrophins in patients with atopic eczema/dermatitis syndrome. Int J Hyg Environ Health 2004, 207(1):45-49. Jan.
108. Kimata H. Effect of exposure to volatile organic compounds on plasma levels of neuropeptides, nerve growth factor and histamine in patients with self-reported multiple chemical sensitivity. Int J Hyg Environ Health 2004, 207(2):159-163. Feb.
109. Kiyohara C., Tanaka K., Miyake Y. Genetic susceptibility to atopic dermatitis. Allergol Int 2008, 57(1):39-56. Mar.
110. Kreindler J.L., Steele C., Nguyen N., Chan Y.R., Pilewski J.M., Alcorn J.F., et al. Vitamin D3 attenuates Th2 responses to Aspergillus fumigatus mounted by CD4+ T cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosis. J Clin Invest 2010, 120(9):3242-3254. Sep 1.
111. Kreutzer R., Neutra R.R., Lashuay N. Prevalence of people reporting sensitivities to chemicals in a population-based survey. Am J Epidemiol 1999, 150(1):1-12. Jul 1.
112. Kuroda Y., Nacionales D.C., Akaogi J., Reeves W.H., Satoh M. Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine. Biomed Pharmacother 2004, 58(5):325-337. Jun.
113. Lau S., Nickel R., Niggemann B., Gruber C., Sommerfeld C., Illi S., et al. The development of childhood asthma: lessons from the German Multicentre Allergy Study (MAS). Paediatr Respir Rev 2002, 3(3):265-272. Sep.
114. Lau D.C., Dhillon B., Yan H., Szmitko P.E., Verma S. Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol 2005, 288(5):H2031-H2041. May.
115. Lax M.B., Henneberger P.K. Patients with multiple chemical sensitivities in an occupational health clinic: presentation and follow-up. Arch Environ Health 1995, 50(6):425-431. Nov-Dec.
116. Lee T.G. Health symptoms caused by molds in a courthouse. Arch Environ Health 2003, 58(7):442-446.
117. Leonard B.E., Song C. Stress, depression, and the role of cytokines. Cytokines, stress, and depression 1999, Kluwer Academic:Plenum Publishers, New York.
118. Lindh U., Hudecek R., Danersund A., Eriksson S., Lindvall A. Removal of dental amalgam and other metal alloys supported by antioxidant therapy alleviates symptoms and improves quality of life in patients with amalgam-associated ill health. Neuroendocrinol Lett 2002, 23(5-6):459-482.
119. Ma X., He P., Sun P., Han P. Lipoic acid: an immunomodulator that attenuates glycinin-induced anaphylactic reactions in a rat model. J Agric Food Chem 2010, 58(8):5086-5092. Apr 28.
120. Maarsingh H., Zaagsma J., Meurs H. Arginine homeostasis in allergic asthma. Eur J Pharmacol 2008, 585(2-3):375-384. May 13.
121. Maarsingh H., Bossenga B.E., Bos I.S., Volders H.H., Zaagsma J., Meurs H. l-arginine deficiency causes airway hyperresponsiveness after the late asthmatic reaction. Eur Respir J 2009, 34(1):191-199. Jul.
122. MacDougald O.A., Burant C.F. The rapidly expanding family of adipokines. Cell Metab 2007, 6(3):159-161. Sep.
123. Mahmoudi M., Gershwin M.E. Sick building syndrome. III. Stachybotrys chartarum. J Asthma 2000, 37(2):191-198. Apr.
124. Mansueto P., Montalto G., Pacor M.L., Esposito-Pellitteri M., Ditta V., Lo Bianco C., et al. Food allergy in gastroenterologic diseases: review of literature. World J Gastroenterol 2006, 12(48):7744-7752. Dec 28.
125. Marshall B. Helicobacter pioneers: firsthand accounts from the scientists who discovered helicobacters 2002, Blackwell, Victoria, Australia.
126. Marshall L., Weir E., Abelsohn A., Sanborn M.D. Identifying and managing adverse environmental health effects: 1. Taking an exposure history. CMAJ 2002, 166:1049-1055.
127. Meggs W.J. Hypothesis for induction and propagation of chemical sensitivity based on biopsy studies. Environ Health Perspect 1997, 105(Suppl 2):473-478. Mar.
128. Meggs W.J. Mechanisms of allergy and chemical sensitivity. Toxicol Ind Health 1999, 15(3-4):331-338. Apr-Jun.
129. Meurs H., Maarsingh H., Zaagsma J. Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyperresponsiveness. Trends Pharmacol Sci 2003, 24(9):450-455. Sep.
130. Michaels D. Doubt is their product: how industry's assault on science threatens your health 2008, Oxford University Press, New York.
131. Miller C.S. Multiple chemical sensitivity syndrome. J Occup Environ Med 1995, 37(12):1323. Dec.
132. Miller C.S. Chemical sensitivity: symptom, syndrome or mechanism for disease?. Toxicology 1996, 111(1-3):69-86. Jul 17.
133. Miller C.S. Toxicant-induced loss of tolerance-an emerging theory of disease?. Environ Health Perspect 1997, 105(Suppl 2):445-453. Mar.
134. Miller C.S. Are we on the threshold of a new theory of disease? Toxicant-induced loss of tolerance and its relationship to addiction and abdiction. Toxicol Ind Health 1999, 15(3-4):284-294. Apr-Jun.
135. Miller C.S., Ashford N.A. Multiple chemical intolerance and indoor air quality. Chapter 27. Indoor air quality handbook 2000, MacGraw-Hill, New York. J.D. Spengler, J.M. Samet, J.F. McCarthy (Eds.).
136. Miller C.S., Mitzel H.C. Chemical sensitivity attributed to pesticide exposure versus remodeling. Arch Environ Health 1995, 50(2):119-129. Mar-Apr.
137. Miller C.S., Prihoda T.J. A controlled comparison of symptoms and chemical intolerances reported by Gulf War veterans, implant recipients and persons with multiple chemical sensitivity. Toxicol Ind Health 1999, 15(3-4):386-397. Apr-Jun.
138. Miller C.S., Prihoda T.J. The Environmental Exposure and Sensitivity Inventory (EESI): a standardized approach for measuring chemical intolerances for research and clinical applications. Toxicol Ind Health 1999, 15:370-385.
139. Millichap J.G., Yee M.M. The diet factor in pediatric and adolescent migraine. Pediatr Neurol 2003, 28(1):9-15. Jan.
140. Moen B., Hollund B., Riise T. Neurological symptoms among dental assistants: a cross-sectional study. J Occup Med Toxicol (London, England) 2008, 3:10.
141. Mok M.Y., Wu H.J., Lo Y., Lau C.S. The Relation of Interleukin 17 (IL-17) and IL-23 to Th1/Th2 Cytokines and Disease Activity in Systemic Lupus Erythematosus. J Rheumatol 2010.
142. Montoro J., Mullol J., Jauregui I., Ferrer M., Bartra J., et al. Stress and allergy. J Investig Allergol Clin Immunol 2009, 19(Suppl 1):40-47.
143. Nantes Castillejo O., Zozaya J., Jimenez-Perez F., Martinez-Penuela J., Borda F. Incidence and characteristics of eosinophilic esophagitis in adults. An Sist Sanit Navar 2009, 32(2):227-234. May-Aug.
144. Nemery B. Late consequences of accidental exposure to inhaled irritants: RADS and the Bhopal disaster. Eur Respir J 1996, 9(10):1973-1976. Oct.
145. Notkins A.L. New predictors of disease. Molecules called predictive autoantibodies appear in the blood years before people show symptoms of various disorders. Tests that detected these molecules could warn of the need to take preventive action. Sci Am 2007, 296(3):72-79. Mar.
146. Nowak-Wegrzyn A., Sicherer S.H. Immunotherapy for food and latex allergy. Clin Allergy Immunol 2008, 21:429-446.
147. Office of Genomics and Disease Prevention: Centers for Disease Control and Prevention. Department of Health and Human S. Gene-Environment Interaction Fact Sheet. 2000.
148. Overstreet D.H., Miller C.S., Janowsky D.S., Russell R.W. Potential animal model of multiple chemical sensitivity with cholinergic supersensitivity. Toxicology 1996, 111(1-3):119-134. Jul 17.
149. Pall M.L. Explaining 'unexplained illness': disease paradigm for chronic fatigue syndrome, multiple chemical sensitivity, fibromyalgia; post-traumatic stress disorder, Gulf War syndrome and others 2007, Harrington Park Press, New York.
150. Pall M.L. Multiple chemical sensitivity: toxicological questions and mechanisms (part eight, chapter 92). General and applied toxicology 2009, Wiley, New Jersey. 3rd Edition. B. Ballantyne, T.C. Marrs, T. Syversen (Eds.).
151. Papageorgiou P.S. Clinical aspects of food allergy. Biochem Soc Trans 2002, 30(Pt 6):901-906. Nov.
152. Pestka J.J., Yike I., Dearborn D.G., Ward M.D., Harkema J.R. Stachybotrys chartarum, trichothecene mycotoxins, and damp building-related illness: new insights into a public health enigma. Toxicol Sci 2008, 104(1):4-26. Jul.
153. Petro T.M. Regulatory role of resveratrol on Th17 in autoimmune disease. Int Immunopharmacol 2010, Aug 12.
154. Postolache T.T., Langenberg P., Zimmerman S.A., Lapidus M., Komarow H., McDonald J.S., et al. Changes in severity of allergy and anxiety symptoms are positively correlated in patients with recurrent mood disorders who are exposed to seasonal peaks of aeroallergens. Int J Child Health Hum Dev 2008, 1(3):313-322.
155. Randolph T.G. Specific adaptation. Ann Allergy 1978, 40(5):333-345. May.
156. Randolph T.G., Moss R. An alternative approach to allergies 1980, Lippincott & Crowell, New York.
157. Rea W.J. Chemical sensitivity: (volume 1): tools of diagnosis and methods of treatment 1992, CRC Press, Boca Raton.
158. Rea W.J. Chemical sensitivity: (volume 4): tools of diagnosis and methods of treatment 1997, Lewis Publishers, Boca Raton.
159. Rea W.J., Pan Y., Fenyves E.J., Sujisawa I., Suyama N., Ross G.H. Electromagnetic field sensitivity. J Bioelectricity 1991, 10:241-256.
160. Reid S., Hotopf M., Hull L., Ismail K., Unwin C., Wessely S. Reported chemical sensitivities in a health survey of United Kingdom military personnel. Occup Environ Med 2002, 59(3):196-198. Mar.
161. Rogers E.M. Diffusion of innovations 1995, The Free Press, New York.
162. Rogers W.R., Miller C.S., Bunegin L. A rat model of neurobehavioral sensitization to toluene. Toxicol Ind Health 1999, 15(3-4):356-369. Apr-Jun.
163. Rowat S.C. Integrated defense system overlaps as a disease model: with examples for multiple chemical sensitivity. Environ Health Perspect 1998, 106(Suppl 1):85-109. Feb.
164. Rubin R.L., Kretz-Rommel A. Initiation of autoimmunity by a reactive metabolite of a lupus-inducing drug in the thymus. Environ Health Perspect 1999, 107(Suppl 5):803-806. Oct.
165. Schambach F., Schupp M., Lazar M.A., Reiner S.L. Activation of retinoic acid receptor-alpha favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. Eur J Immunol 2007, 37:2396-2399.
166. Schnare D.W., Denk G., Shields M., Brunton S. Evaluation of a detoxification regimen for fat stored xenobiotics. Med Hypothesis 1982, 9:265-282.
167. Sears M. The medical perspective on environmental sensitivities 2007, Canadian Human Rights Commission, Government of Canada, ([available at http://www.chrc-ccdp.ca/research_program_recherche/esensitivities_hypersensibilitee/toc_tdm-en.asp] accessed Oct 11/2009.).
168. Segal B.M. Th17 cells in autoimmune demyelinating disease. Semin Immunopathol 2010, 32:71-77.
169. Shannon A., Alkhouri N., Mayacy S., Kaplan B., Mahajan L. Low-dose naltrexone for treatment of duodenal Crohn's disease in a pediatric patient. Inflamm Bowel Dis 2010, 16(9):1457. Sep.
170. Shields M., Beckman S.L., Cassidy-Brinn G. Improvement in perception of transcutaneous nerve stimulation following detoxification in firefighters exposed to PCBs, PCDDs and PCDFs. Clin Ecol 1989, 6:47-50.
171. Sicherer S.H., Sampson H.A. Food allergy. J Allergy Clin Immunol 2010, 125(Suppl 2):S116-S125. Feb.
172. Sih T., Mion O. Allergic rhinitis in the child and associated comorbidities. Pediatr Allergy Immunol 2010, Aug 2.
173. Simon G.E., Katon W.J., Sparks P.J. Allergic to life: psychological factors in environmental illness. Am J Psychiatry 1990, 147(7):901-906. Jul.
174. Simon T.R., Hickey D.C., Fincher C.E., Johnson A.R., Ross G.H., Rea W.J. Single photon emission computed tomography of the brain in patients with chemical sensitivities. Toxicol Ind Health 1994, 10(4-5):573-577. Jul-Oct.
175. Smith J.P., Stock H., Bingaman S., Mauger D., Rogosnitzky M., Zagon I.S. Low-dose naltrexone therapy improves active Crohn's disease. Am J Gastroenterol 2007, 102(4):820-828. Apr.
176. Sorg B.A. Multiple chemical sensitivity: potential role for neural sensitization. Crit Rev Neurobiol 1999, 13(3):283-316.
177. Sorg B.A., Hochstatter T. Behavioral sensitization after repeated formaldehyde exposure in rats. Toxicol Ind Health 1999, 15(3-4):346-355. Apr-Jun.
178. Sorg B.A., Willis J.R., See R.E., Hopkins B., Westberg H.H. Repeated low-level formaldehyde exposure produces cross-sensitization to cocaine: possible relevance to chemical sensitivity in humans. Neuropsychopharmacology 1998, 18(5):385-394. May.
179. Spergel J.M., Andrews T., Brown-Whitehorn T.F., Beausoleil J.L., Liacouras C.A. Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann Allergy Asthma Immunol 2005, 95(4):336-343. Oct.
180. Staren E.D., Essner R., Economou J.S. Overview of biological response modifiers. Semin Surg Oncol 1989, 5(6):379-384.
181. Staudenmayer H. Idiopathic environmental intolerances (IEI): myth and reality. Toxicol Lett 2001, 120(1-3):333-342. Mar 31.
182. Staudenmayer H., Selner M.E., Selner J.C. Adult sequelae of childhood abuse presenting as environmental illness. Ann Allergy 1993, 71(6):538-546. Dec.
183. Stejskal V., Stejskal J. Toxic metals as a key factor in disease. Forword. Neuro Endocrinol Lett 2006, 27(Suppl 1):3-4. Dec.
184. Stejskal V.D., Danersund A., Lindvall A., Hudecek R., Nordman V., Yaqob A., et al. Metal-specific lymphocytes: biomarkers of sensitivity in man. Neuro Endocrinol Lett 1999, 20(5):289-298.
185. Sterzl I., Prochazkova J., Hrda P., Matucha P., Bartova J., Stejskal V. Removal of dental amalgam decreases anti-TPO and anti-Tg autoantibodies in patients with autoimmune thyroiditis. Neuro Endocrinol Lett 2006, 27(Suppl 1):25-30. Dec.
186. Steyn PS, Gelderblom WC, Shephard GS, van Heerden FR. Mycotoxins with a special focus on aflatoxins, ochratoxins and fumonisins. (Part fourteen, chapter 146) In General and Applied Toxicology, 3rd Edition. Ballantyne B, Marrs TC, and Syversen T (Eds). New Jersey: Wiley.
187. Tabershaw I.R., Cooper W.C. Sequelae of acute organic phosphate poisoning. J Occup Med 1966, 8(1):5-20. Jan.
188. Tay S.S., Clark A.T., Deighton J., King Y., Ewan P.W. Patterns of immunoglobulin G responses to egg and peanut allergens are distinct: ovalbumin-specific immunoglobulin responses are ubiquitous, but peanut-specific immunoglobulin responses are up-regulated in peanut allergy. Clin Exp Allergy 2007, 37(10):1512-1518. Oct.
189. Terr A.I. Sick building syndrome: is mould the cause?. Med Mycol 2009, 47(Suppl 1):S217-S222.
190. Tracey K.J. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 2007, 117(2):289-296. Feb.
191. Tracey K.J. Reflex control of immunity. Nat Rev Immunol 2009, 9(6):418-428. Jun.
192. Tretjak Z., Shields M., Beckman S.L. PCB reduction and clinical improvement by detoxification: an unexploited approach. Hum Exp Toxicol 1990, 9:235-244.
193. Uchigata Y., Hirata Y., Iwamoto Y. Drug-induced insulin autoimmune syndrome. Diab Res Clin Pract 2009, 83(1):e19-e20. Jan.
194. University of Maryland Medical Centre. (accessed Jan 17, 2010). Allergies Health Guide. http://www.umm.edu/allergies/stats.htm.
195. Valverde C. A judge in Spain grants full disability for chemical sensitivities for environmental accident 2010, [accessed August 12, 2010 at http://sacfs.asn.au/news/2010/07/07_03_spanish_court_case.htm].
196. van den Oord R.A., Sheikh A. Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis. BMJ 2009, 339:b2433.
197. Vojdani A. Antibodies as predictors of complex autoimmune diseases and cancer. Int J Immunopathol Pharmacol 2008, 21(3):553-566. Jul-Sep.
198. Welch L.S., Sokas R. Development of multiple chemical sensitivity after an outbreak of sick-building syndrome. Toxicol Ind Health 1992, 8(4):47-50. Jul-Aug.
199. Wilders-Truschnig M., Mangge H., Lieners C., Gruber H., Mayer C., Marz W. IgG antibodies against food antigens are correlated with inflammation and intima media thickness in obese juveniles. Exp Clin Endocrinol Diab 2008, 116(4):241-245. Apr.
200. Wojcik D.P., Godfrey M.E., Christie D., Haley B.E. Mercury toxicity presenting as chronic fatigue, memory impairment and depression: diagnosis, treatment, susceptibility, and outcomes in a New Zealand general practice setting (1994-2006). Neuro Endocrinol Lett 2006, 27(4):415-423. Aug.
201. Xie L., Li X.K., Funeshima-Fuji N., Kimura H., Matsumoto Y., Isaka Y., et al. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production. Int Immunopharmacol 2009, 9:575-581.
202. Younger J., Mackey S. Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study. Pain Med (Malden, Mass.) 2009, 10(4):663-672. May-Jun.
203. Yu I.T., Lee N.L., Zhang X.H., Chen W.Q., Lam Y.T., Wong T.W. Occupational exposure to mixtures of organic solvents increases the risk of neurological symptoms among printing workers in Hong Kong. J Occup Environ Med 2004, 46(4):323-330. Apr.
204. Yum H.Y., Lee S.Y., Lee K.E., Sohn M.H., Kim K.E. Genetically modified and wild soybeans: an immunologic comparison. Allergy Asthma Proc 2005, 26(3):210-216. May-Jun.
205. Zagon I.S., Rahn K.A., Turel A.P., McLaughlin P.J. Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis. Exp Biol Med (Maywood) 2009, 234(11):1383-1392. Nov.
206. Zibrowski E.M., Robertson J.M. Olfactory sensitivity in medical laboratory workers occupationally exposed to organic solvent mixtures. Occup Med (Oxford, England) 2006, 56(1):51-54. Jan.
207. Ziem G.E. Multiple chemical sensitivity: treatment and followup with avoidance and control of chemical exposures. Toxicol Ind Health 1992, 8(4):73-86. Jul-Aug.
208. Ziem G., McTamney J. Profile of patients with chemical injury and sensitivity. Environ Health Perspect 1997, 105(Suppl 2):417-436.